U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07444073) titled 'Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock' on Feb. 12.
Brief Summary: This study examines whether routine treatment with semaglutide or tirzepatide, prescribed with lifestyle coaching in a real-world weight-management program, is associated with changes in biological age measured by the LinAge2 clinical aging clock over 6 months.
Study Start Date: Feb. 02
Study Type: OBSERVATIONAL
Condition:
Aging
Obesity & Overweight
Intervention:
OTHER: Not applicable. This is an observational study.
Not applicable. This is an observational study.
Recruitment Status: NOT_YET_REC...